Is Evonik’s Massive Global Expansion of Hydroxyl-Terminated Polybutadiene (HTPB) a Technological Ambition — or a Geopolitical Gamble?

To most observers, the name Evonik may evoke images of feed additives, cosmetic ingredients, or automotive coatings. But on February 9, 2026, the German chemical giant quietly released what can only be described as a “strategic depth charge”: a significant global expansion of hydroxyl-terminated polybutadiene (HTPB) capacity — not only launching the first phase of expansion at its Marl site in Germany, scheduled to come online in Q2 2027, but also planning the construction of an entirely new HTPB plant in Asia.

The announcement may appear routine, but beneath the surface it is anything but calm. HTPB is no ordinary chemical — it is the core binder in solid rocket propellants, the “invisible bloodstream” of missiles, launch vehicles, and strategic weapons systems. Evonik’s move is ostensibly commercial expansion, yet it sits squarely at the intersection of high-end material autonomy, defense supply chain security, and intensifying geopolitical rivalry.

When a European company known for its commitment to “sustainable specialty chemicals” makes a bold investment in a highly sensitive defense-related material, one must ask: is this a confident expression of technological leadership, or a calculated bet on a rapidly shifting global security landscape?

HTPB: “German Precision” Hidden Inside Rockets

HTPB — hydroxyl-terminated polybutadiene — may sound technical, but its role is critical. In solid rocket motors, it serves as the binder between fuel and oxidizer (such as ammonium perchlorate). It must withstand extreme temperatures and pressures while maintaining chemical stability over years of storage, ensuring precise energy release at ignition.

A single gram of impurity can doom a launch. A slight variation in batch performance can render an entire missile ineffective.

For this reason, only a handful of companies worldwide can reliably mass-produce high-purity, high-consistency HTPB. Key players include Cordis (formerly a DuPont subsidiary) in the United States, JSR in Japan, and Gujarat Narmada Valley Fertilizers & Chemicals (GNFC) in India. Evonik, through its POLYVEST® HT series, has long dominated the European and high-end global market.

Over the past two years, Evonik has been quietly positioning itself. In 2024, it expanded HTPB capacity at its Marl site. In 2025, it commissioned a POLYVEST ST-E 60 polybutadiene plant in Shanghai — not explicitly labeled as HTPB, but technologically adjacent. Now, with the formal announcement of “Asian greenfield plant + further German expansion,” Evonik is signaling its intent: not only to secure Europe’s defense supply chain, but also to penetrate the Asia-Pacific region, currently the most dynamic aerospace and defense market globally.

Notably, Evonik has not disclosed the location of the Asian facility, stating only that it will be chosen “based on synergies with existing assets.” Industry speculation points toward Taiwan, South Korea, or Singapore — regions with advanced semiconductor ecosystems, strong integration into U.S.–Japan–Korea defense structures, and growing demand for high-performance propulsion materials, while maintaining manageable political risk.

Application Areas and Market Structure

Information synthesized from ESA, NDIA reports, and industry supply chain research.

The HTPB market is highly stratified: civil applications are negotiable, military applications are restricted, and strategic-level systems are nearly opaque. Evonik’s expansion clearly targets the first two tiers — especially those “middle powers” seeking enhanced launch autonomy without complete reliance on U.S. or Russian supply chains.

Why Now? Global Security Anxiety and the Rise of “Materials Nationalism”

Evonik’s timing is far from coincidental.

Since 2023, geopolitical conflicts have intensified, and supply chain security has evolved from a commercial issue into a matter of national survival. Europe is accelerating its pursuit of “strategic autonomy.” Germany’s Future Capabilities Act has identified key raw materials and specialty chemicals as priority sectors. The United States has invoked Title III of the Defense Production Act to support domestic propellant supply chains. India’s Atmanirbhar Bharat initiative has poured investment into indigenous missile programs. Japan and South Korea are expanding next-generation ballistic missile and satellite launch capabilities.

All of these trends converge on one demand: reducing reliance on single-source HTPB suppliers.

Historically, many European states depended on U.S. suppliers. However, after the Russia–Ukraine conflict, Washington prioritized domestic and core allied needs, lengthening procurement cycles and driving up prices for secondary NATO members. India’s GNFC offers local supply, but its formulations reportedly lag Evonik in high-energy adaptability.

By expanding capacity now, Evonik is effectively offering reassurance to anxious clients: “We do not sell weapons — but we provide the materials that make them reliable.”

Strategically, this expansion also reflects Evonik’s internal transformation. In recent years, the company has divested commodity chemical segments and focused on high-barrier, high-margin specialty chemicals. HTPB maintains margins above 40%, with strong client stickiness and contract cycles spanning three to five years — effectively a premium “cash engine.” In an era of macroeconomic volatility, such business segments offer far greater resilience than cyclical consumer-facing chemicals.

Building in Asia: Closer to Customers — or Closer to the Powder Keg?

Yet the greatest risk lies precisely in the decision to build in Asia.

On the surface, this is a conventional move: proximity to customers, reduced delivery times, mitigation of trade barriers. But HTPB’s unique sensitivity ensures that any production footprint becomes a geopolitical statement.

If the plant is located within the U.S.–Japan alliance framework, it may strengthen Western supply chains but risk antagonizing Beijing. If placed in a neutral Southeast Asian country, it could face heightened concerns over technology leakage or export control complexities.

The dilemma deepens when considering China itself. China has already achieved significant HTPB self-sufficiency through institutions such as the Aerospace Science and Technology Corporation and Liming Chemical Research Institute. Its commercial space sector is expanding rapidly.

If Evonik were to build in mainland China, military-grade licensing would likely be unattainable. If it refrains, it risks missing a major civil launch market. This is the paradox facing multinational specialty chemical companies in a fragmented global order: politics cannot be ignored, especially when the molecules you produce determine how far a missile can travel.

Materials as Power: The Silent Battlefield Heats Up

Evonik’s HTPB expansion may appear as yet another chemical capacity announcement. In reality, it is a mirror reflecting the true nature of 21st-century industrial competition.

High-end manufacturing is no longer about factories and patents alone — it is embedded in the neural networks of national security strategies.

As SpaceX redefines launch economics with reusable rockets, as nations deploy hypersonic weapons, as satellite constellations become instruments of digital sovereignty, control over foundational materials like HTPB becomes a strategic lever.

Evonik’s CEO may frame this as specialty chemical growth. But its Marl facility — and its future Asian plant — are no longer merely production sites. They are smokeless arsenals, fortifications built not from steel, but from molecular architecture.

And in this new era, chemistry is not just industry. It is influence.